We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

225 hedge funds and large institutions have $1.38B invested in Rocket Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 97 increasing their positions, 44 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 25

120% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 44

18% more funds holding

Funds holding: 191 → 225 (+34)

1.25% more ownership

Funds ownership: 101.86% → 103.11% (+1.3%)

9% less call options, than puts

Call options by funds: $2.08M | Put options by funds: $2.28M

19% less capital invested

Capital invested by funds: $1.71B → $1.38B (-$331M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
225
Holders Change
+34
Holders Change %
+17.8%
% of All Funds
2.96%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
59
Increased
97
Reduced
44
Closed
25
Calls
$2.08M
Puts
$2.28M
Net Calls
-$194K
Net Calls Change
-$3.77M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$41.4M
2
SCM
Suvretta Capital Management
New York
+$38.6M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$31.7M
4
Citadel Advisors
Citadel Advisors
Florida
+$29.7M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$22.9M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$16.2M
2
Millennium Management
Millennium Management
New York
-$13M
3
BAMCO Inc
BAMCO Inc
New York
-$12.2M
4
FTM
First Turn Management
California
-$11.5M
5
PA
Perceptive Advisors
New York
-$8.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
51
Ikarian Capital
Texas
$2.79M +$374K +24,815 +13%
Walleye Capital
52
Walleye Capital
New York
$2.77M +$1.23M +81,739 +59%
Renaissance Technologies
53
Renaissance Technologies
New York
$2.75M +$3.29M +218,519 New
ACM
54
ADAR1 Capital Management
Texas
$2.66M +$3.12M +207,100 +4,816%
OCM
55
Ovata Capital Management
Hong Kong
$2.51M +$3.01M +200,000 New
Bank of New York Mellon
56
Bank of New York Mellon
New York
$2.44M +$150K +9,949 +5%
ECM
57
ExodusPoint Capital Management
New York
$2.39M +$1.87M +124,261 +189%
TD Asset Management
58
TD Asset Management
Ontario, Canada
$2.24M +$12.7K +844 +0.5%
Mirae Asset Global ETFs Holdings
59
Mirae Asset Global ETFs Holdings
Hong Kong
$2.23M +$60K +3,985 +2%
N
60
Nuveen
North Carolina
$2.11M – – –
HCA
61
Harbor Capital Advisors
Illinois
$2.08M -$50.9K -3,379 -2%
SF
62
Synovus Financial
Georgia
$2.06M +$1.03M +68,389 +72%
EAM
63
Exome Asset Management
New York
$2.01M +$2.4M +159,552 New
BNP Paribas Financial Markets
64
BNP Paribas Financial Markets
France
$1.99M +$1.8M +119,482 +307%
Rafferty Asset Management
65
Rafferty Asset Management
New York
$1.96M +$414K +27,534 +21%
Swiss National Bank
66
Swiss National Bank
Switzerland
$1.93M +$438K +29,100 +23%
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.92M +$2.95K +196 +0.1%
NLVP
68
New Leaf Venture Partners
New York
$1.89M – – –
EAM
69
EFG Asset Management
Oregon
$1.83M -$1.49M -98,791 -40%
UBS AM
70
UBS AM
Illinois
$1.75M +$300K +19,939 +17%
ACP
71
Acuta Capital Partners
California
$1.69M -$835K -55,500 -29%
Fidelity Investments
72
Fidelity Investments
Massachusetts
$1.63M -$5.06M -335,922 -72%
Nordea Investment Management
73
Nordea Investment Management
Sweden
$1.6M +$7.54K +501 +0.4%
SA
74
Sovran Advisors
California
$1.57M +$2.27M +150,767 New
Citigroup
75
Citigroup
New York
$1.55M +$1.08M +71,919 +140%
1 2
3
4 5

RCKT Hedge Fund Activity: Q4 2024 in Review

225 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q4 2024, worth a combined $1.38B — down 19% from $1.71B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new RCKT positions and 25 closed out — a net gain of 34 holders — while 97 added to existing stakes and 44 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $41.4M. The largest seller was Franklin Resources, cutting an estimated $16.2M.

  • 225 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q4 2024, up from 191 in Q3 2024.
  • Funds reported $1.38B of Rocket Pharmaceuticals stock for Q4 2024, down 19% quarter-over-quarter.
  • 59 funds opened new Rocket Pharmaceuticals positions in Q4 2024 and 25 closed out, a net change of +34 holders.
  • The largest Rocket Pharmaceuticals buyer in Q4 2024 was Wellington Management Group, an estimated $41.4M added.
  • The largest Rocket Pharmaceuticals seller in Q4 2024 was Franklin Resources, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2024.